Home/Enterome/Marie-Laure Bouttier
MB

Marie-Laure Bouttier

Chief Corporate Officer, Co-founder

Enterome

Therapeutic Areas

Enterome Pipeline

DrugIndicationPhase
EO2463Indolent Non-Hodgkin Lymphomas (Follicular Lymphoma)Phase 2
EO2401Glioblastoma and Adrenal TumorsPhase 2
EO4010Third-line Colorectal CancerPhase 2